Zynlonta 10 mg lyophilized powder for injection Images
Generic Name: loncastuximab tesirine
This medication has been identified as Zynlonta 10 mg lyophilized powder for injection. It is supplied by ADC Therapeutics SA.
Zynlonta is used in the treatment of Diffuse Large B-Cell Lymphoma and belongs to the drug class miscellaneous antineoplastics. Zynlonta 10 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zynlonta
- Generic Name
- loncastuximab tesirine
- Strength
- 10 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ADC Therapeutics SA
- National Drug Code (NDC)
- 79952-0110
More about Zynlonta (loncastuximab tesirine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.